Latest Information Update: 02 Dec 2003
At a glance
- Originator Sepracor
- Mechanism of Action Proton pump inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- No development reported Gastro-oesophageal reflux
Most Recent Events
- 02 Dec 2003 No development reported - Preclinical for Gastro-oesophageal reflux in USA (unspecified route)
- 18 Apr 2001 Preclinical development for Gastro-oesophageal reflux in USA (Unknown route)